[Headlines Only] [Top Stories Only]
Categories
· Cessation
· Business (General)
· Vaccines

Nabi Biopharmaceuticals to Hold Conference Call 

Jump to full article: CNN, 2009-11-16
Author: CONTACT: Nabi Biopharmaceuticals Investor Relations 301-770-3099 www.nabi.com

Intro:

Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will host a live webcast and conference call at 11:00 a.m. ET on Tuesday, November 17 to discuss today's announcement of the exclusive worldwide option and licensing agreement for NicVAX(R), a nicotine conjugate candidate vaccine, between GlaxoSmithKline Biologicals SA and Nabi Biopharmaceuticals.

Jump to full article »